X Bioscience (SET:XBIO) extended the deadline for selling its shares in Fruita Biomed to June 30, 2027, with the revised sale price reduced to 110 baht per share from 274.22 baht per share.
The company said the buyer's liquidity constraints and Fruita's weaker-than-expected performance prompted the changes, according to a Friday filing.
X Bioscience said it has recognized cumulative impairment losses of 270.6 million baht on the Fruita investment through the second quarter of 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.